Concepts (204)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fertility Preservation | 4 | 2023 | 22 | 1.500 |
Why?
|
| Oocytes | 10 | 2020 | 221 | 1.320 |
Why?
|
| Granulosa Cells | 6 | 2020 | 32 | 1.250 |
Why?
|
| Follicle Stimulating Hormone | 6 | 2020 | 147 | 1.030 |
Why?
|
| Anti-Mullerian Hormone | 2 | 2018 | 11 | 0.780 |
Why?
|
| Cumulus Cells | 6 | 2019 | 7 | 0.660 |
Why?
|
| Ovulation Induction | 5 | 2014 | 34 | 0.640 |
Why?
|
| Abortion, Spontaneous | 1 | 2018 | 66 | 0.600 |
Why?
|
| Somatomedins | 1 | 2017 | 28 | 0.580 |
Why?
|
| Luteinizing Hormone | 4 | 2014 | 167 | 0.530 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2012 | 181 | 0.510 |
Why?
|
| Ovary | 3 | 2012 | 261 | 0.470 |
Why?
|
| Infertility, Female | 3 | 2014 | 96 | 0.430 |
Why?
|
| Glycoproteins | 2 | 2012 | 234 | 0.420 |
Why?
|
| Oogenesis | 3 | 2012 | 45 | 0.410 |
Why?
|
| Reproduction | 1 | 2011 | 199 | 0.350 |
Why?
|
| Insulin-Like Growth Factor II | 3 | 2020 | 33 | 0.350 |
Why?
|
| Follicular Fluid | 6 | 2016 | 10 | 0.340 |
Why?
|
| Piperazines | 1 | 2011 | 283 | 0.340 |
Why?
|
| Ovarian Hyperstimulation Syndrome | 1 | 2008 | 5 | 0.330 |
Why?
|
| Pyrimidines | 1 | 2011 | 372 | 0.320 |
Why?
|
| Cholestasis | 1 | 2008 | 45 | 0.310 |
Why?
|
| Ovarian Follicle | 4 | 2017 | 72 | 0.300 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 2 | 2004 | 16 | 0.270 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 2 | 2004 | 19 | 0.270 |
Why?
|
| Receptors, Adrenergic, beta-2 | 3 | 2002 | 36 | 0.260 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2004 | 108 | 0.260 |
Why?
|
| Chorionic Gonadotropin | 4 | 2019 | 72 | 0.260 |
Why?
|
| Cells, Cultured | 7 | 2020 | 2880 | 0.250 |
Why?
|
| Growth Differentiation Factor 9 | 3 | 2020 | 3 | 0.240 |
Why?
|
| Bone Morphogenetic Protein 15 | 3 | 2020 | 3 | 0.240 |
Why?
|
| Gene Expression Regulation | 5 | 2020 | 1975 | 0.230 |
Why?
|
| Fertilization in Vitro | 3 | 2019 | 57 | 0.230 |
Why?
|
| Fertility | 1 | 2023 | 116 | 0.220 |
Why?
|
| Gonadotropin-Releasing Hormone | 2 | 2014 | 108 | 0.210 |
Why?
|
| Female | 22 | 2020 | 46014 | 0.200 |
Why?
|
| Aromatase | 2 | 2019 | 12 | 0.200 |
Why?
|
| Oocyte Retrieval | 2 | 2012 | 7 | 0.190 |
Why?
|
| Cell Differentiation | 3 | 2017 | 1521 | 0.190 |
Why?
|
| Receptor, IGF Type 1 | 2 | 2019 | 45 | 0.190 |
Why?
|
| Pregnancy | 5 | 2018 | 3010 | 0.180 |
Why?
|
| Fertilization | 2 | 2018 | 40 | 0.180 |
Why?
|
| Humans | 24 | 2023 | 89073 | 0.180 |
Why?
|
| Transgender Persons | 1 | 2022 | 105 | 0.180 |
Why?
|
| Meiosis | 3 | 2016 | 82 | 0.180 |
Why?
|
| Antineoplastic Agents | 1 | 2011 | 2412 | 0.180 |
Why?
|
| Culture Media, Conditioned | 1 | 2020 | 103 | 0.170 |
Why?
|
| Epidermal Growth Factor | 2 | 2010 | 117 | 0.170 |
Why?
|
| Signal Transduction | 7 | 2019 | 3374 | 0.170 |
Why?
|
| Luteal Cells | 1 | 2019 | 2 | 0.170 |
Why?
|
| Receptors, LH | 1 | 2019 | 7 | 0.170 |
Why?
|
| Sp1 Transcription Factor | 1 | 2019 | 21 | 0.170 |
Why?
|
| Amphiregulin | 3 | 2014 | 6 | 0.150 |
Why?
|
| Biomarkers | 2 | 2017 | 1755 | 0.150 |
Why?
|
| Gonadal Steroid Hormones | 2 | 2022 | 51 | 0.130 |
Why?
|
| Oncogene Protein v-akt | 1 | 2015 | 21 | 0.130 |
Why?
|
| Ovulation | 2 | 2011 | 68 | 0.120 |
Why?
|
| Stem Cell Niche | 1 | 2014 | 22 | 0.120 |
Why?
|
| Spermatozoa | 1 | 2014 | 62 | 0.120 |
Why?
|
| Hormone Antagonists | 1 | 2014 | 19 | 0.120 |
Why?
|
| Pregnancy Rate | 1 | 2014 | 21 | 0.120 |
Why?
|
| RNA, Messenger | 5 | 2019 | 2011 | 0.120 |
Why?
|
| Cyclic GMP | 1 | 2014 | 59 | 0.120 |
Why?
|
| Cyclic AMP | 4 | 2020 | 274 | 0.120 |
Why?
|
| Sperm Injections, Intracytoplasmic | 2 | 2012 | 8 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinases | 4 | 2002 | 226 | 0.110 |
Why?
|
| Cell Culture Techniques | 1 | 2014 | 192 | 0.110 |
Why?
|
| Progesterone | 2 | 2010 | 110 | 0.110 |
Why?
|
| Metaphase | 1 | 2012 | 25 | 0.110 |
Why?
|
| Imatinib Mesylate | 1 | 2011 | 127 | 0.100 |
Why?
|
| Cryopreservation | 1 | 2011 | 74 | 0.100 |
Why?
|
| Adult | 9 | 2022 | 26508 | 0.090 |
Why?
|
| EGF Family of Proteins | 1 | 2010 | 3 | 0.090 |
Why?
|
| Betacellulin | 1 | 2010 | 3 | 0.090 |
Why?
|
| Epiregulin | 1 | 2010 | 3 | 0.090 |
Why?
|
| Endometrium | 1 | 2010 | 50 | 0.090 |
Why?
|
| Benzamides | 1 | 2011 | 237 | 0.090 |
Why?
|
| Endometriosis | 1 | 2010 | 59 | 0.090 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2011 | 173 | 0.090 |
Why?
|
| Gentamicins | 1 | 2010 | 20 | 0.090 |
Why?
|
| Chorioamnionitis | 1 | 2010 | 21 | 0.090 |
Why?
|
| Mitosis | 1 | 2010 | 152 | 0.090 |
Why?
|
| Phosphorylation | 5 | 2004 | 1130 | 0.080 |
Why?
|
| Infertility | 1 | 2009 | 37 | 0.080 |
Why?
|
| Primary Cell Culture | 2 | 2020 | 76 | 0.080 |
Why?
|
| Hormones | 1 | 2009 | 139 | 0.080 |
Why?
|
| Smad2 Protein | 2 | 2019 | 20 | 0.080 |
Why?
|
| Smad3 Protein | 2 | 2019 | 23 | 0.080 |
Why?
|
| Pregnancy Trimester, First | 1 | 2008 | 63 | 0.080 |
Why?
|
| Animals | 11 | 2014 | 27324 | 0.080 |
Why?
|
| CHO Cells | 3 | 2004 | 187 | 0.080 |
Why?
|
| Risk Factors | 1 | 2018 | 5466 | 0.070 |
Why?
|
| Cricetinae | 3 | 2004 | 558 | 0.070 |
Why?
|
| Treatment Outcome | 4 | 2014 | 8203 | 0.070 |
Why?
|
| Pregnancy Outcome | 1 | 2008 | 253 | 0.070 |
Why?
|
| Enzyme Activation | 3 | 2004 | 698 | 0.070 |
Why?
|
| Prognosis | 2 | 2011 | 3773 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2017 | 1940 | 0.070 |
Why?
|
| Adenylyl Cyclases | 2 | 2004 | 100 | 0.070 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 2004 | 8 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 1 | 2010 | 786 | 0.060 |
Why?
|
| ErbB Receptors | 2 | 2014 | 500 | 0.060 |
Why?
|
| Cell Proliferation | 3 | 2016 | 1650 | 0.060 |
Why?
|
| Adenylate Cyclase Toxin | 1 | 2002 | 14 | 0.050 |
Why?
|
| Virulence Factors, Bordetella | 1 | 2002 | 26 | 0.050 |
Why?
|
| Pertussis Toxin | 1 | 2002 | 31 | 0.050 |
Why?
|
| GTP-Binding Proteins | 1 | 2002 | 145 | 0.050 |
Why?
|
| Intention | 1 | 2022 | 51 | 0.050 |
Why?
|
| Parenting | 1 | 2022 | 68 | 0.050 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 2000 | 18 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2002 | 1012 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2020 | 202 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 2000 | 261 | 0.040 |
Why?
|
| Adolescent | 1 | 2011 | 9237 | 0.040 |
Why?
|
| Steroids | 1 | 2019 | 174 | 0.040 |
Why?
|
| Time Factors | 3 | 2014 | 5320 | 0.040 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 1997 | 73 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 1706 | 0.030 |
Why?
|
| Ligands | 2 | 2012 | 443 | 0.030 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 1997 | 191 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2016 | 105 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2017 | 727 | 0.030 |
Why?
|
| Natriuretic Peptide, C-Type | 1 | 2014 | 8 | 0.030 |
Why?
|
| Spermatogenesis | 1 | 2014 | 37 | 0.030 |
Why?
|
| Adult Stem Cells | 1 | 2014 | 29 | 0.030 |
Why?
|
| Middle Aged | 2 | 2010 | 25865 | 0.030 |
Why?
|
| Cell Separation | 1 | 2014 | 198 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2022 | 2612 | 0.030 |
Why?
|
| Testis | 1 | 2014 | 152 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 2016 | 388 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2014 | 277 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2014 | 691 | 0.030 |
Why?
|
| Blastocyst | 1 | 2012 | 35 | 0.030 |
Why?
|
| Nucleotides, Cyclic | 1 | 2011 | 11 | 0.030 |
Why?
|
| Kidney | 1 | 1997 | 1145 | 0.020 |
Why?
|
| Transcriptional Activation | 2 | 2004 | 291 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2012 | 284 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 374 | 0.020 |
Why?
|
| COS Cells | 2 | 2002 | 167 | 0.020 |
Why?
|
| Gap Junctions | 1 | 2011 | 144 | 0.020 |
Why?
|
| Peritoneal Diseases | 1 | 2010 | 16 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2011 | 128 | 0.020 |
Why?
|
| Child | 1 | 2022 | 7149 | 0.020 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2010 | 18 | 0.020 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2010 | 70 | 0.020 |
Why?
|
| Drug Resistance | 1 | 2010 | 232 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2010 | 240 | 0.020 |
Why?
|
| Validation Studies as Topic | 1 | 2009 | 16 | 0.020 |
Why?
|
| Diagnostic Techniques, Endocrine | 1 | 2009 | 7 | 0.020 |
Why?
|
| DNA Primers | 1 | 2010 | 543 | 0.020 |
Why?
|
| Macaca mulatta | 1 | 2012 | 466 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2011 | 387 | 0.020 |
Why?
|
| Prolactin | 1 | 2009 | 89 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2014 | 1990 | 0.020 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2009 | 50 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2010 | 996 | 0.020 |
Why?
|
| Models, Biological | 2 | 2009 | 1764 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 887 | 0.020 |
Why?
|
| Estradiol | 1 | 2009 | 250 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2010 | 894 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2010 | 308 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2009 | 590 | 0.020 |
Why?
|
| Testosterone | 1 | 2009 | 275 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2010 | 755 | 0.020 |
Why?
|
| Protein Binding | 2 | 2002 | 1487 | 0.020 |
Why?
|
| Base Sequence | 1 | 2010 | 2327 | 0.020 |
Why?
|
| Gene Expression | 1 | 2010 | 1310 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2010 | 1855 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2010 | 1715 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 1429 | 0.020 |
Why?
|
| Plasmids | 1 | 2004 | 291 | 0.010 |
Why?
|
| Transfection | 1 | 2004 | 911 | 0.010 |
Why?
|
| Isoproterenol | 1 | 2002 | 62 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2002 | 71 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2002 | 77 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 2002 | 146 | 0.010 |
Why?
|
| Hydrolysis | 1 | 2002 | 141 | 0.010 |
Why?
|
| Dimerization | 1 | 2002 | 143 | 0.010 |
Why?
|
| Binding Sites | 1 | 2004 | 1117 | 0.010 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2000 | 67 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2000 | 117 | 0.010 |
Why?
|
| Cell Division | 1 | 2002 | 696 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2000 | 116 | 0.010 |
Why?
|
| Sodium-Hydrogen Exchangers | 1 | 2000 | 77 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2009 | 4273 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2002 | 740 | 0.010 |
Why?
|
| Young Adult | 1 | 2012 | 6289 | 0.010 |
Why?
|
| Clathrin | 1 | 2000 | 29 | 0.010 |
Why?
|
| Mice | 1 | 2014 | 11742 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2014 | 9003 | 0.010 |
Why?
|
| Point Mutation | 1 | 2000 | 245 | 0.010 |
Why?
|
| Male | 2 | 2014 | 42254 | 0.010 |
Why?
|
| Endocytosis | 1 | 2000 | 180 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2000 | 565 | 0.010 |
Why?
|
| Peptides | 1 | 2002 | 647 | 0.010 |
Why?
|
| Cell Line | 1 | 2002 | 2495 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1997 | 313 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1997 | 302 | 0.010 |
Why?
|
| Acute Disease | 1 | 1997 | 841 | 0.010 |
Why?
|
| Homeostasis | 1 | 1997 | 413 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1997 | 948 | 0.010 |
Why?
|
| Mutation | 1 | 2004 | 4132 | 0.010 |
Why?
|
| Insulin | 1 | 1997 | 1146 | 0.010 |
Why?
|
| Rats | 1 | 1997 | 4041 | 0.010 |
Why?
|